Market News & Trends
Evonik Launches EUDRACAP Colon Functional Capsules for the Targeted Delivery of Oral Drugs
Evonik is expanding its EUDRACAP portfolio with a new functional, ready-to-fill capsule that enables the delivery of sensitive active ingredients to the ileo-colonic region. EUDRACAP…
Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program for the Treatment of Ulcerative Colitis
Palisade Bio, Inc. recently provided an update on its progress toward the launch of its Phase 1 human clinical study for PALI-2108 for the treatment of…
Sanner Group Acquires Gilero to Expand Global Medical Device Offering
Sanner Group has acquired Gilero LLC, a world class medical device design, development, and contract manufacturer headquartered in Durham, NC. The addition of Gilero will…
GoLiver Therapeutics Awarded Innovation in Biotherapies & Bioproduction Call for its GOCLINICALS Project Dedicated to Novel Stem Cell-Based Liver Therapy
GoLiver Therapeutics recently announced it has won the Innovations in Biotherapies and Bioproduction call for proposal launched by the French government to make France a…
Aptar CSP Technologies’ N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
Aptar CSP Technologies recently announced its N-Sorb nitrosamine mitigation solution has been accepted into the US FDA's Emerging Technology Program (ETP), which helps promote the…
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical & Commercial Supply of Advanced Drug Delivery & Drug-Device Combination Products
PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced…
Lonza & Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY
Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, recently announced the signature of a long-term commercial supply agreement for CASGEVY (exagamglogene…
Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor pharma
Quell Therapeutics Ltd and eXmoor pharma recently announced a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune…
KSQ Therapeutics Announces FDA Clearance of IND Application for a CRISPR/Cas9 Engineered Tumor-Infiltrating Lymphocyte Therapy
KSQ Therapeutics, Inc., in collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) and the Cell Therapy Manufacturing Center (CTMC), recently announced…
Araris Biotech AG Expands IP Portfolio With Acquisition of Innate Pharma’s Portfolio
Araris Biotech AG recently announced it has entered into an agreement with Innate Pharma. Under the agreement, Innate will assign its portfolio of patents related…
Barinthus Bio Initiates Phase 1 Clinical Trial of for the Treatment of Celiac Disease
Barinthus Biotherapeutics plc recently announced the initiation of its first-in-human Phase 1 trial of VTP-1000 in adults with celiac disease. The randomized, placebo-controlled clinical trial,…
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
Lipella Pharmaceuticals Inc. recently announced an update on its ongoing multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP).…
Zevra’s MIPLYFFA Receives FDA Approval for Use in Patients With Niemann-Pick Disease Type C
XOMA Royalty Corporation recently announced Zevra Therapeutics has received approval from the US FDA for MIPLYFFA (arimoclomol). MIPLYFFA is approved for use in combination with…
European Microbiome Innovation for Health & Microbiome Therapeutics Innovation Group Announce New Collaboration
The European Microbiome Innovation for Health (EMIH) association recently announced an agreement between the Microbiome Therapeutics Innovation Group (MTIG) and EMIH for a collaboration to advance…
Assembly Biosciences Reports Positive Interim Phase 1a Results From Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate
Assembly Biosciences, Inc. recently announced positive interim pharmacokinetic (PK) and safety results from healthy participants in the Phase 1a portion of its ongoing Phase 1a/b…
Ventyx Biosciences Announces $27-Million Strategic Investment From Sanofi
Ventyx Biosciences, Inc. recently announced Sanofi has agreed to make a $27-million strategic investment in the company at an as-converted price of $3.8243 per share…
Hovione & iBET Announce the Establishment of a Venture in Cell & Gene Therapy Solutions
Hovione and iBET recently announced the official establishment of ViSync Technologies as a jointly owned venture. The creation of this new company, headquartered in the…
Lonza Launches Innovaform Accelerator, the New Innovation & Formulation Center in Colmar (FR)
Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, recently inaugurated its new facility at the Colmar (FR) site. The new Innovaform…
Tiziana Life Sciences Announces $4-Million Grant to Study Anti-CD3 in Alzheimer’s Disease
Tiziana Life Sciences, Ltd. recently announced the National Institutes of Health (NIH), National Institute on Aging have awarded a $4-million grant to Dr. Howard Weiner…
Oncolytics Biotech Reports Favorable Results for BRACELET-1 Breast Cancer Study
Oncolytics Biotech Inc. recently announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep in patients with HR+/HER2- advanced or metastatic breast cancer.…
